Minerva Neurosciences

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-5
-7
-7
EBITDA
-4,270
22,518
-5,913
-6,310
EBIT
-4,272
22,513
-5,921
-6,318
Net Income
-4,272
22,513
-8,233
-8,568
Net Change In Cash
0
0
0
0
Free Cash Flow
-5,166
-14,383,772,968
-3,937
-6,094
Cash
21,362
26,528
30,981
34,918
Basic Shares
7,573
7,568
7,568
7,568

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-30
-8
-101
EBITDA
-21,848,386
-21,691
-24,693
-51,607
EBIT
6,001
-21,722
-24,702
-51,709
Net Income
1,438
-30,005
-38,986
-49,905
Net Change In Cash
0
0
0
0
Free Cash Flow
-19,550,567
-14,784
-24,661
-24,601
Cash
21,362
40,912
36,093
60,755
Basic Shares
7,573
6,506
5,340
5,340

Earnings Calls

Quarter EPS
2024-12-31
-$0.56
2024-09-30
-$0.54
2024-06-30
-$1.09
2024-03-31
-$1.13